To investigate the role of ARHGEF12 in regulating the growth and chemoresistance of GC cells, we initially treated the cells with 5-FU, oxaliplatin, and docetaxel-three commonly used chemotherapeutic agents for GC treatment. Here, ARHGEF12 is linked to gastric cancer.